Related references
Note: Only part of the references are listed.Uncoupling the Dopamine D1-D2 Receptor Complex: A Novel Target for Antidepressant Treatment
A. H. C. Wong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy
David Taylor et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice
T. Deltheil et al.
NEUROPHARMACOLOGY (2008)
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine
A Harkin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Mechanisms and state of the art of vagus nerve stimulation
M Kosel et al.
JOURNAL OF ECT (2002)
A new phenolic amide from Lycium chinense Miller
SH Han et al.
ARCHIVES OF PHARMACAL RESEARCH (2002)
Effects of Kampo herbal medicine on plasma melatonin concentration in patients
H Watanabe et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2002)
The role of functional neuroimaging in the neuropsychology of depression
M Liotti et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2001)
Share Paper
